Synergistic Antitumor Activities of Docetaxel and Octreotide Associated with Apoptotic-Upregulation in Castration-Resistant Prostate Cancer

Androgen deprivation therapy has become the fist-line treatment of metastatic prostate cancer; however, progression to castrate resistance disease occurs in the majority of patients. Thus, there is an urgent need for improvements in therapy for castration-resistant prostate cancer. The aims of the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Sha, Oremo, Judith Apondi, Li, Sanqiang, Zhen, Minghui, Tang, Yue, Du, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954761/
https://www.ncbi.nlm.nih.gov/pubmed/24632829
http://dx.doi.org/10.1371/journal.pone.0091817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954761/
https://www.ncbi.nlm.nih.gov/pubmed/24632829
http://dx.doi.org/10.1371/journal.pone.0091817

Ejemplares similares